Physician profile
Pooja Narwal
NPI 1578841763
$783.01
in general payments reported to CMS, 2019-2025
13 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.72 · 2021: $13.89 · 2022: $11.71 · 2024: $380 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.89 | 2019-2025 | |
| Dexcom, INC. | $149.33 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $100.57 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Lilly USA, LLC | $71.40 | 2022-2025 | Jardiance |
| Amgen INC. | $68.17 | 2021-2025 | Tepezza |
| Abbott Laboratories | $62.59 | 2024-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $58.54 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ibsa Pharma INC. | $24.37 | 2025 | Tirosint, Flector, Licart |
| Endo Pharmaceuticals INC. | $20.90 | 2019 | |
| Medtronic, INC. | $19.46 | 2024 | Minimed 780g |
| Antares Pharma, INC. | $18.65 | 2024 | Xyosted |
| Intra-Sana Laboratories | $17.53 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Merck Sharp & Dohme LLC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Narwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.